If you invest in the stock market, you must know the Pfizer stock forecast & price prediction for 2025, 2026, 2027, 2028, 2029, and 2030. Here, you will get the detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
Pfizer Inc (PFE) Company Overview
In 1849, Charles Fizer and Charles F. Erhart founded Pfizer Inc., a leading American multinational pharmaceutical and biotechnology corporation headquartered in The Spiral, New York City.
With a mission to deliver life-changing breakthroughs to patients, Pfizer focuses on developing and manufacturing medicines and vaccines in diverse therapeutic areas, including immunology, oncology, cardiology, endocrinology, and neurology.
Under the leadership of Chairman and CEO Albert Bourla, Pfizer has achieved significant milestones, most notably the development of the Pfizer-BioNTech COVID-19 vaccine, which generated $11 billion in revenue in 2023.
The company’s diverse portfolio also includes well-known products such as Eliquis (a blood thinner), Prevnar (a pneumococcal vaccine), and Ibrance (a treatment for breast cancer). The company continues to invest in research and development, with a focus on innovative areas such as gene therapy, mRNA technology, and artificial intelligence, aimed at addressing unmet medical needs and improving global health outcomes.
Pfizer Inc. (PFE) Fundamental Analysis
| मार्केट कैप | $134,924 Mln. |
| ROE | 0.09% |
| ROCE | 5.08% |
| P/E अनुपात | 16.87 |
| P/B अनुपात | 1.56 |
| Div. यील्ड | 7.23% |
| बुक वैल्यू | — |
| ईपीएस (टीटीएम) | $1.38 |
| 52 सप्ताह | $31.54 |
| 52 सप्ताह कम | $20.92 |
यह भी पढ़ें: रिवियन स्टॉक पूर्वानुमान
Pfizer स्टॉक पूर्वानुमान 2025
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $27.18 by early 2025.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $27.12
By the end of 2025, Pfizer’s stock price can achieve the target of $30.75.
| वर्ष 2025 | |
|---|---|
| मूल्य | $27.18 |
| मध्य वर्ष की कीमत | $27.12 |
| समाप्ति मूल्य | $30.75 |
Pfizer स्टॉक पूर्वानुमान 2026
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $31.12 by early 2026.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $33.85.
By the end of 2026, Pfizer’s stock price can achieve the target of $36.70.
| वर्ष 2026 | |
|---|---|
| मूल्य | $31.12 |
| मध्य वर्ष की कीमत | $33.85 |
| समाप्ति मूल्य | $36.70 |
Pfizer Stock Forecast 2027
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $37.24 by early 2027.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $39.56.
By the end of 2027, Pfizer’s stock price can achieve the target of $42.10.
| वर्ष 2027 | |
|---|---|
| मूल्य | $37.24 |
| मध्य वर्ष की कीमत | $39.56 |
| समाप्ति मूल्य | $42.10 |
यह भी पढ़ें: डेल स्टॉक पूर्वानुमान
Pfizer Stock Forecast 2028
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $189.43 by early 2028.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $202.35.
By the end of 2028, Pfizer’s stock price can achieve the target of $218.50.
| वर्ष 2028 | |
|---|---|
| मूल्य | $189.43 |
| मध्य वर्ष की कीमत | $202.35 |
| समाप्ति मूल्य | $218.50 |
Pfizer Stock Forecast 2029
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $50.30 by early 2029.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $53.24.
By the end of 2029, Pfizer’s stock price can achieve the target of $56.18.
| वर्ष 2029 | |
|---|---|
| मूल्य | $50.30 |
| मध्य वर्ष की कीमत | $53.24 |
| समाप्ति मूल्य | $56.18 |
Pfizer स्टॉक पूर्वानुमान 2030
After analyzing Pfizer’s past price trends and market performance, it is estimated that the stock could reach $57.10 by early 2030.
By the middle of the year, driven by market demand and sector performance, the price could rise to around $60.42.
By the end of 2030, Pfizer’s stock price can achieve the target of $63.00.
| वर्ष 2030 | |
|---|---|
| मूल्य | $57.10 |
| मध्य वर्ष की कीमत | $60.42 |
| समाप्ति मूल्य | $63.00 |
यह भी पढ़ें: एप्पल स्टॉक पूर्वानुमान
Pfizer Stock Forecast & Price Prediction 2025 To 2030
| वर्ष | Stock Price Forecast |
|---|---|
| 2025 | $30.75 |
| 2026 | $36.70 |
| 2027 | $42.10 |
| 2028 | $49.65 |
| 2029 | $56.18 |
| 2030 | $63.00 |
Pfizer Inc. Major Holdings
| Shares Held by All Insider | 0.06% |
| Shares Held by Institutions | 67.60% |
| Float Held by Institutions | 67.63% |
| संस्थाओं की संख्या होल्डिंग शेयर | 3,677 |
यह भी पढ़ें: NVDA स्टॉक पूर्वानुमान
Pfizer Inc. (PFE) Financials
| आय विवरण | ||
|---|---|---|
| Category | 2024 Value | वाई / वाई |
| राजस्व | $63.63B | 6.84% |
| संचालन व्यय | $30.88B | 5.58% |
| कुल आय | $8.03B | 279.00% |
| नेट लाभ मार्जिन | 12.62% | 254.49% |
| प्रति शेयर कमाई | $3.11 | 69.02% |
| EBITDA | $23.32B | 24.22% |
| प्रभावी कर दर | -0.35% | — |
| बैलेंस शीट | ||
|---|---|---|
| Category | 2024 Value | वाई / वाई |
| Cash & Short-Term Investments | $20.48B | 61.36% |
| कुल परिसंपत्तियां | $213.40B | -5.79% |
| कुल देयता | $124.90B | -8.97% |
| कुल इक्विटी | $88.50B | — |
| शेयर बकाया | 5.67B | — |
| मूल्य बुक | 1.43 | — |
| परिसंपत्तियों पर वापसी | 4.64% | — |
| पूंजी पर वापसी | 6.37% | — |
| नकदी प्रवाह विवरण | ||
|---|---|---|
| Category | 2024 Value | वाई / वाई |
| कुल आय | $8.03B | 279.00% |
| Cash From Operations | $12.74B | 46.48% |
| Cash From Investing | $2.65B | 108.22% |
| Cash From Financing | -$17.14B | -165.76% |
| नकद में नेट बदलें | -$1.81B | -173.91% |
| फ्री कैश फ्लो | $12.78B | 129.78% |
यह भी पढ़ें: Mr Cooper Group (COOP) Stock Forecast
Pfizer Inc (PFE) Top Shareholders
| कंपनी | प्रतिशतता |
|---|---|
| वैनगार्ड ग्रुप इंक | 9.14% |
| Blackrock Inc. | 7.97% |
| राज्य सड़क निगम | 5.12% |
| Charles Schwab Investment Management, Inc. | 2.74% |
| वेलिंगटन मैनेजमेंट ग्रुप, एलएलपी | 2.47% |
| जियोडे कैपिटल मैनेजमेंट, LLC | 2.13% |
| NORGES BANK | 1.55% |
| मैसाचुसेट्स वित्तीय सेवा कंपनी | 1.35% |
| मॉर्गन स्टैनले | 1.30% |
| उत्तरी ट्रस्ट निगम | 1.03% |

